Please wait a minute...
93TMR Cancer  2019, Vol. 2 Issue (4): 233-238    DOI: 10.12032/TMRC201800059
Integrative Oncology     
Miao medicine may serve as an essential adjuvant therapy in cancer treatment
Dong-Xue Sun1, Zhu Yang1, Feng-Xi Long1, Ming-Zhu Li1, Guo Chen1, Dong-Xin Tang1,2,*()
1Guizhou University of Traditional Chinese Medicine, Guiyang 550002, China.
2First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, NO.71 Baoshan North Road, Yuyan District, Guiyang 550001, China.
Download: HTML     PDF(542KB)
Export: BibTeX | EndNote (RIS)      


Miao medicine may serve as an adjuvant therapy in cancer treatment.

Miao medicine may reduce the recurrence and metastasis rate after tumor surgery.


Traditional Chinese medicine includes many kinds of regional ethnic medicine, such as Miao medicine. Miao medicine has unique insights in cancer treatment. Studies on Miao medicine is still insufficient, its unique treatment methods may bring new ideas to cancer treatment. The use of Miao medicine in treating cancer may require more experimental and clinical evidence


The Miao people have formed a unique treatment method for diseases in the long-term survival and development process, which lead to the formation of Miao medicine. Miao medicine is a kind of regional ethnic medicine in traditional Chinese medicine. Many studies and clinical trials have proved that Miao medicine played an active role in the prevention, treatment, and rehabilitation of tumors, which may reduce the recurrence and metastasis rate after tumor surgery, and decrease the toxic and side effects caused by radiotherapy and chemotherapy. Furthermore, Miao medicine may improve immunity and prolong the overall survival of patients with tumor. All these indicate that Miao medicine may serve as an essential adjuvant therapy. This article describes the specific application of Miao medicine in clinical and provides a scientific basis of Miao medicine in the treatment of cancer.

Key wordsMiao medicine      Tumor      Combination therapy     
Received: 13 June 2019      Published: 20 September 2019
Corresponding Authors: Tang Dong-Xin   
Cite this article:

Dong-Xue Sun, Zhu Yang, Feng-Xi Long, Ming-Zhu Li, Guo Chen, Dong-Xin Tang. Miao medicine may serve as an essential adjuvant therapy in cancer treatment. 93TMR Cancer, 2019, 2(4): 233-238. doi: 10.12032/TMRC201800059

URL:     OR

Name Mechanism
Tripterygium [30] Down-regulation of VEGFR-2, VEGF, COX-2, COX-1, MMP-9, TIE, et al.; inhibition of NF-κB, Akt signaling pathway
Panax ginseng [31] Regulation of HIF-1α, VEGF expression, inhibition of PI3K/Akt and ERK1/2 pathway
Scutellaria Baicalensis [32] Inhibition of VEGF, down-regulation of MMPs; inhibition of p53/Rb signaling pathway, down-regulation of LPSTLR4-TRAF6 pathway
Sophora [33] Down-regulation of MMP-9, MMP-2 expression, inhibition of NF-κB pathway
Asarum Sieboldii [34] Inhibition of HPV-DNA proliferation
Gekko [34] Inhibit tumor cell invasion and metastasis, up-regulate E-calpain, down-regulate Racl, VEGF expression level
Curcuma Longa [35] Inhibits VEGF and receptor expression, regulates NF-Kβ, Akt/mTOR signaling pathway
Whitmania [36] Inhibition of Ki-67 proliferating antigen and high expression of VEGF
Table 1 Anti-tumor neovascularization and related mechanisms of some Miao herbs
1.   Ferlay J, Ervik M, Bray F, et al. Global cancer observatory: cancer today. Lyon, France: International Agency for Research on Cancer. .
doi: 10.1186/s12885-019-6184-1 pmid: 31604464
2.   Zhang J, Li XF, Liu Y, et al. Progress in cancer epidemiology status quo and anti-tumor medicine. Shandong Chemical 2015, 44: 42-44.
3.   Chen WQ, Li H, Sun KX, et al. Analysis of the incidence and mortality of malignant tumors in China in 2014. Chin J Oncol 2018, 40: 5-13.
doi: 10.3760/cma.j.issn.0253-9624.2019.11.016 pmid: 31683405
4.   Long L. Brief introduction of Miao medicine. Chin National Folk Med 2007, 89: 349-351.
doi: 10.1007/s00261-004-0253-9 pmid: 15776302
5.   Wang FL, Liu Y, Leng Y. On the understanding of cancer by Miao medicine. Guizhou Prov Assoc Tradit Chin & West Med Anorectal Soc Acad Exch. 2012, 3-10.
doi: 10.3389/fimmu.2019.02329 pmid: 31632404
6.   Du J, Zhang BF. Miao medicine prevention and health care method. Chin J Tradit Med 2004, S1: 238-239.
7.   Du J. Methods and characteristics of Miao medicine treatment. Chin J Med 2007, 22: 483-485.
doi: 10.1007/s11655-016-2458-5 pmid: 27081001
8.   Loizzo MR, Bonesi M, Passalacqua NG, et al. Anti-proliferative activities on renal, prostate and melanoma cancer cell lines of sarcopoterium spinosum aerial parts and its major constituent tormentic acid. Anticancer Agents Med Chem 2013, 13: 768-769.
doi: 10.2174/1871520611313050011 pmid: 23157592
9.   Zhang GZ, Li YH. Clinical application of scraping in chronic pain disease. J Hebei Univ Tradit Chin Med 2009, 24: 41.
10.   Zeng J, Mai RY, Yan JW, et al. Anti-tumor mechanism of water-containing phlegm and blood stasis based on network pharmacology. Guangxi Med J Learn 2019, 4: 467-472.
11.   Liu JS, Miao ZH, Dong L, et al. Experimental study on anti-tumor effect of Shuizhi. Shizhen Tradit Chin Med 2001, 12: 884-885.
12.   Zhang Y, Zhao W, Li XH, et al. Molecular mechanism of Miao medicine black vine on lung cancer prevention and treatment based on network pharmacology. Chin Tradit Med 2019, 2: 399-404.
13.   Li W, An HM, Shen KP, et al. Antitumor effect and clinical application of Duchesnea Indica Focke. World Chin Med, 2019, 14: 264-268.
doi: 10.1155/2019/6407210 pmid: 31781632
14.   Zhou W, Ge Zx, Bi W. Analysis of the efficacy of complement-dissolved Miao medicine combined with chemotherapy in the treatment of lung cancer. Liaoning J Tradit Chin Med 2012, 3: 470-471.
doi: 10.1155/2015/408145 pmid: 26347788
15.   Zhu Y, Huang SY, Wang W, et al. Review of anti-tumor mechanism and clinical application of Agrimonia pilosa. World Sci Technol-Mod Tradit Chin Med 2018, 12: 2196-2201.
doi: 10.19540/j.cnki.cjcmm.20190610.402 pmid: 31602900
16.   Xu YF, Liu YX, Shen MH, et al. Strategies and research progress of traditional Chinese medicine in reversing multidrug resistance of tumors. Chin J Integr Tradit & West Med 2015, 35: 891-896.
pmid: 16970104
17.   Yan M, Liu HY, Liu ZH, et al. Reversal of drug resistance of T24/ADM cells by cyclosporine A and Matrine. Chin Med Front 2010, 5: 69-70.
18.   He Y, Shi JL, Chen R, et al. The therapeutic effect of Chanchu on tumors. World Latest Med Inform Abstr 2016, 7: 35-36.
19.   He HY, Xie CS. Research progress of traditional Chinese medicine in preventing and treating bone marrow suppression after chemotherapy for malignant tumors. J Tradit Chin Med 2017, 35: 67-70.
20.   Liu JQ, Liu J, Jiang W, et al. Study on quality standards of Herba Pteridis multifidae. Chin J Tradit Chin Med 2015, 40: 1855-1859.
doi: 10.1016/j.wasman.2019.11.020 pmid: 31812094
21.   Cancer pain diagnosis and treatment standards (2018 edition). Gen Pract Med Educ 2019, 17: 4-8.
22.   Shui HL, Yang Z, Cui W, et al. The similarities and differences between Miao and TCM in treating cancer pain. J Tradit Chin Med 2017, 24: 2158-2160.
23.   Du J, Deng YH, Yang HJ. Secret treating methods of Chinese Miao medicine. Guizhou Sci Technol Press 2014: 20-193
24.   He MHY. Investigation on the distribution of and the extraction process of Tripterygium Wilfordii. Guizhou Univ Natl 2016, 105-130.
doi: 10.1039/c9dt02383f pmid: 31524896
25.   Peng T. Preparation of analgesic sustained-release pellets by extrusion spheronization and sustained-release coating. Chin J New Drugs 2011, 18: 1809-1812.
doi: 10.1208/s12249-018-1119-8 pmid: 30091062
26.   Yang SM, Zhu TY. Nursing research on patients with cervical spondylosis treated by Miao medicine separated medicine fire moxibustion. World Medl Inform Digest 2018, 18: 174-175, 179.
27.   Liu XX, Yang Z, Cui W, et al. Contrasting the understanding of TCM and Miao medicine on cancer-related fatigue. Shizhen Tradit Chin Med, 2018, 271: 158-159.
28.   Lu KZ, Wang FR, et al. Miao medicine. Guiyang: Guizhou Sci Technol Press 2006, 07: 28-30
29.   He HY, Xie CS. Research progress of traditional Chinese medicine in preventing and treating bone marrow suppression after chemotherapy for malignant tumors. J Tradit Chin Med 2017, 35: 67-70.
30.   Naila A, Wang G, Zhang YF. Research progress of anti-tumor angiogenesis of Triptolide. Advances in Anatomy 2015, 21: 556-559.
doi: 10.19540/j.cnki.cjcmm.20190610.402 pmid: 31602900
31.   Xu J, Song Z, Guo Q, et al. Synergistic effect and molecular mechanisms of traditional Chinese medicine on regulating tumor microenvironment and cancer cells. Biomed Res Int 2016, 5: 1490738.
doi: 10.1155/2016/1490738 pmid: 27042656
32.   Ma XG, Gao XY, Yan YJ, et al. Research status and recent progress of anti-tumor mechanism of baicalein. West Med 2016, 28: 430-436.
33.   Huang H, Du T, Xu G, et al. Matrine suppresses invasion of castration-resistant prostate cancer cells by downregulating MMP-2/9 via NF-κB signaling pathway. Internat J Oncol 2016, 50: 640.
doi: 10.3892/ijo.2016.3805
34.   Deng YH, Feng Y, Sun J, et al. Study on the effect of Asarum on human papillomavirus. Tradit Chin Med 2004, 27: 665-666.
doi: 10.7326/M17-1609 pmid: 29181509
35.   Ge WJ, Duan LQ, Liu L, et al. Study on the inhibition of migration and invasion of human cervical cancer SiHa cells by ethanol extract of Gecko. Chin J Clin Pharmacol 2016, 32: 913-916.
36.   Shi WJ, Jia YJ. Progress in anti-angiogenic Chinese medicine for the treatment of gastric cancer. Asia Pac Tradit Med 2018, 14: 69-71.
pmid: 15734710
37.   Ren QH, Qi ZX, Yan YJ, et al. Effects of hirudin on the expression of Ki-67 and VEGF in tumor-bearing mice. J Med Res 2010, 39: 46-48.
[1] Yi-Dan Sun, Ying Zhang, Pei-Ying Yang, Ying-Jie Jia. The effect of Cordyceps Sinensis in the prognosis on patients receiving chemotherapy with malignant tumors: A systematic review and meta-analysis[J]. 93TMR Cancer, 2020, 3(1): 19-27.
[2] Fan-Ming Kong, Yang Yao, Ren-Fen Deng, Tian-Qi Chen, Dong-Ying Liao, Xiao-Jiang Li, Ying-Jie Jia. Xiaoyan decoction inhibits tumor growth and improves the immunity of mouse with A549 lung carcinoma xenograft[J]. 93TMR Cancer, 2019, 2(4): 227-232.
[3] Jia Wang, Zhu Yang, Feng-Xi Long, Jin-Lin Wu, Ting Yu, Dong-Xin Tang. The role of Fuzheng Peiben in clinical oncology[J]. 93TMR Cancer, 2019, 2(4): 247-251.
[4] Hui-Li Shui, Zhu Yang , Feng-Xi Long , Wen-Qi Huang , Bing Yang , Zhen Zhang , Dong-Xin Tang. The differences and similarities between regional ethnic medicine and traditional Chinese medicine in the prevention and treatment of cancer pain[J]. 93TMR Cancer, 2019, 2(3): 206-211.
[5] Xin-Xiao Lu, Xiong-Zhi Wu. Anti-tumor mechanism of Angelica and its compound preparations[J]. 93TMR Cancer, 2019, 2(2): 193-199.
[6] Gao Li, Dong-Xin Tang, Feng-Xi Long, Zhu Yang. Advances in research on tumor microenvironment of hepatocellular carcinoma[J]. 93TMR Cancer, 2019, 2(1): 143-150.
[7] e-Ming Yu, Kai-Li Wang, Bing-Jie Wang, Lei Fang, Meng-Na Liu, Xin-Xin Fan, Hong-Jie Mu, Da-Quan Chen. Research progress of polysaccharide nanocarriers based on traditional Chinese medicine Thallus japonica[J]. 93TMR Cancer, 2018, 1(3): 82-86.
[8] Yu Qiao. Advances in the relationship between Hashimoto’s thyroiditis and thyroid cancer[J]. 93TMR Cancer, 2018, 1(3): 66-73.